Embecta Corp. (EMBC) Key Metrics

NASDAQ: EMBCValuation, returns, debt and efficiency ratios over 7 years.

EMBC valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$355.3M
Enterprise value
$1.59B
P/E (TTM)
4.3
10-yr median 9.6
Forward P/E
—
PEG ratio
—
Price / sales
0.3
10-yr median 0.8
Price / book
2.6
EV / EBITDA
6.0
10-yr median 8.9
Dividend yield
0.64%
$0.04 a year
Beta
0.83

EMBC key metrics, FY2019–FY2025

Fiscal year ended September 30, 2025 · U.S. dollars

EMBC valuation Price multiples at each fiscal year-end price.

P/E ratio−17.0%
8.7
FY2025 · hover or tap a bar for each year
FY2022: 7.3FY2023: 12.3 (+68.1%)FY2024: 10.5 (−14.9%)FY2025: 8.7 (−17.0%)
FY2019FY2025
Price / sales+5.1%
0.8
FY2025 · hover or tap a bar for each year
FY2022: 1.5FY2023: 0.8 (−46.7%)FY2024: 0.7 (−5.6%)FY2025: 0.8 (+5.1%)
FY2019FY2025
EV / EBITDA−36.2%
7.2
FY2025 · hover or tap a bar for each year
FY2022: 8.8FY2023: 8.9 (+0.6%)FY2024: 11.2 (+26.2%)FY2025: 7.2 (−36.2%)
FY2019FY2025
Price / free cash flow−89.0%
4.6
FY2025 · hover or tap a bar for each year
FY2022: 4.2FY2023: 21.1 (+398.6%)FY2024: 41.3 (+95.9%)FY2025: 4.6 (−89.0%)
FY2019FY2025
Free cash flow yield+19.5 pts
21.9%
FY2025 · hover or tap a bar for each year
FY2022: 23.6%FY2023: 4.7% (−18.9 pts)FY2024: 2.4% (−2.3 pts)FY2025: 21.9% (+19.5 pts)
FY2019FY2025

EMBC valuation history

Fiscal year-endToday7-year median

EMBC returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

EMBC debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

EMBC cash returned to shareholders

DividendsBuybacksFree cash flow

EMBC price vs earnings per share

Share price at year-endEPS (right axis)

EMBC key metrics

FY2019–FY2025
Embecta Corp. key metrics by fiscal year
FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Valuation
Market capitalization$831.3M$822.4M$869.3M$1.64B———
Enterprise value$2.04B$2.16B$2.18B$2.96B———
P/E ratio8.710.512.37.3———
Price / sales0.80.70.81.5———
Price / free cash flow4.641.321.14.2———
Price / operating cash flow4.323.012.84.0———
EV / sales1.91.91.92.6———
EV / EBITDA7.211.28.98.8———
EV / free cash flow11.2108.752.97.6———
Earnings yield11.5%9.5%8.1%13.6%———
Free cash flow yield21.9%2.4%4.7%23.6%———
Dividend yield4.2%4.2%4.0%0.5%———
Shareholder yield (dividends + buybacks)4.9%4.6%4.4%0.5%———
Share price at fiscal year-end$14.11$14.10$15.05$28.79———
Per share
Revenue per share$18.34$19.26$19.41$19.80$20.51$19.04$19.46
Earnings per share$1.62$1.34$1.22$3.92$7.30$7.50$7.58
Operating cash flow per share$3.25$0.61$1.17$7.22$8.03$8.75$8.86
Free cash flow per share$3.10$0.34$0.71$6.80$7.34$8.01$7.65
Cash per share$3.83$4.59$5.65$5.80———
Book value per share−$11.05−$12.66−$14.23−$15.62$10.46$10.04$10.12
Tangible book value per share−$11.43−$13.06−$14.65−$16.05$9.86$9.51$9.56
Dividends per share$0.59$0.59$0.60$0.15$0.15$0.15$0.15
Capex per share$0.16$0.27$0.46$0.42$0.69$0.74$1.21
Debt per share$24.28$27.58$28.37$28.81$0.07$0.09—
Shares outstanding58.9M58.3M57.8M57.1M56.8M57.0M57.0M
Change in shares outstanding+1.0%+1.0%+1.2%+0.4%−0.3%0.0%—
Returns & profitability
Return on equity (ROE)————71.1%74.4%74.9%
Return on invested capital (ROIC)39.9%31.9%33.5%64.6%70.2%74.3%75.2%
Return on assets (ROA)8.0%6.3%6.1%23.9%54.4%57.7%58.0%
Return on tangible assets8.9%6.2%5.9%21.1%55.0%60.4%60.6%
Free cash flow margin16.9%1.8%3.7%34.4%35.8%42.1%39.3%
Income quality (OCF / net income)2.010.460.961.841.101.171.17
Financial health
Total debt$1.43B$1.61B$1.64B$1.64B$4.1M$5.0M—
Cash & short-term investments$225.5M$267.5M$326.5M$330.9M———
Net debt$1.20B$1.34B$1.31B$1.31B$4.1M$5.0M—
Debt / equity————0.010.01—
Debt / assets1.311.251.351.510.010.01—
Net debt / EBITDA4.246.965.353.920.010.01—
Current ratio2.412.032.122.211.781.721.97
Quick ratio1.731.581.691.801.060.971.17
Interest coverage3.11.62.18.2164.0—251.0
Working capital$369.9M$387.0M$395.6M$363.7M$128.0M$98.0M$122.0M
Invested capital$553.6M$602.6M$490.3M$421.5M$598.1M$577.0M$577.0M
Tangible asset value−$673.6M−$762.0M−$846.4M−$916.0M$560.0M$542.0M$587.0M
Net current asset value−$1.11B−$1.26B−$1.29B−$1.31B$98.0M$69.0M$122.0M
Graham number————$41.45$41.16$41.55
Graham net-net per share−$22.33−$25.45−$28.05−$27.48−$0.39−$0.44$0.35
Capital allocation
Dividends paid$35.0M$34.5M$34.4M$8.6M$8.6M$8.6M$8.6M
Share buybacks (net)$5.7M$3.0M$3.6M————
Dividend payout ratio36.7%44.1%48.9%3.8%2.1%2.0%2.0%
Dividends + buybacks / free cash flow22.3%188.4%92.2%2.2%2.1%1.9%2.0%
Capex / revenue0.9%1.4%2.4%2.1%3.3%3.9%6.2%
Capex / operating cash flow4.9%44.3%39.1%5.8%8.6%8.4%13.7%
Capex / depreciation0.230.440.810.761.031.091.92
Stock-based compensation / revenue2.9%2.3%1.9%1.7%1.1%1.2%1.1%
R&D / revenue2.0%7.0%7.6%5.8%5.4%5.6%5.6%
SG&A / revenue30.9%32.5%30.5%26.1%20.6%19.8%20.0%
Efficiency
Days sales outstanding67.043.26.728.142.441.541.8
Days of inventory on hand159.4149.8135.3123.9110.0114.7114.1
Days payables outstanding75.266.946.749.252.154.853.1
Cash conversion cycle (days)151.2126.195.3102.8100.3101.4102.8
Receivables turnover5.448.4554.2812.988.618.798.73
Payables turnover4.855.467.827.427.016.666.87
Inventory turnover2.292.442.702.953.323.183.20
Asset turnover0.910.900.971.211.531.461.49
Average receivables$198.4M$132.9M$20.6M$87.0M$135.3M$123.5M$127.0M
Average payables$82.6M$72.2M$47.5M$47.8M$52.1M$48.5M$47.0M
Average inventory$175.1M$161.8M$137.4M$120.4M$110.0M$101.5M$101.0M
Intangibles / total assets2.1%1.8%2.0%2.3%4.3%4.1%4.3%

Computed from EMBC's annual financial statements (latest annual report filed November 25, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

EMBC valuation and financial ratios

At the end of fiscal 2025 (September 30, 2025), Embecta traded at 8.7 times earnings, against a 7-year median of 9.6. Based on the latest twelve months, the trailing P/E is 4.3. Embecta earned a return on invested capital of 39.9% in fiscal 2025. It ended the year with $1.4 billion of debt and $225.5 million in cash and short-term investments, net debt of $1.2 billion. It returned $40.7 million to shareholders: $35.0 million in dividends and $5.7 million in share buybacks, 22% of free cash flow. The share count rose 3.4% from 57.0M to 58.9M over 6 years.

See the EMBC income statement, the EMBC chart for price history, or the EMBC stock overview for the latest quote and news.

EMBC key metrics FAQ

What is Embecta's P/E ratio?

Embecta's trailing P/E ratio is 4.3 based on the last twelve months of earnings (as of October 17, 2026). At the end of fiscal 2025 it was 8.7, compared with a 7-year median of 9.6.

What is Embecta's EV/EBITDA?

Embecta's enterprise value was 7.2 times EBITDA at the end of fiscal 2025 (enterprise value $2.0 billion, EBITDA $284.3 million); the current EV/EBITDA is 6.0.

What is Embecta's ROIC?

Embecta's return on invested capital was 39.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Embecta have?

Embecta had total debt of $1.4 billion at the end of fiscal 2025 and $1.2 billion of net debt (4.24 times EBITDA).

What is Embecta's dividend yield?

Embecta's forward dividend yield is 0.64%. Embecta paid $35.0 million in dividends in fiscal 2025 ($0.59 per share), a payout ratio of 36.7%.

Does Embecta buy back its shares?

Yes. Embecta spent $5.7 million on net share repurchases in fiscal 2025 Shares outstanding changed +1.0% over the year, to 58.9M..

What is Embecta's free cash flow yield?

Embecta generated $182.4 million of free cash flow in fiscal 2025, a free cash flow yield of 21.9% on its market value at year-end ($831.3 million).

What is Embecta's current ratio?

Embecta's current ratio was 2.41 at the end of fiscal 2025: current assets were 2.41 times current liabilities.

Medical Instruments & Supplies key metrics